NCT07392476

Continuous Glucose Monitoring in Polycystic Ovarian Syndrome

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 40 (estimated)
• Sponsor: The Cleveland Clinic · Academic / Other
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome. The patient will be asked to wear a continuous glucose monitor (CGM) device that is applied to the arm with a sensor or filament that goes under the skin to measure your sugar levels. The patient will wear this at certain time points throughout the study. There will have a total of 2 blood draws (about 1 tsp. of blood) at screening and the 6-month visit, a measure of the patients body muscle and fat (body composition), and fill out a questionnaire at the end of the first 3 months and 6 months. Study participation in the research will last about 6 months.

Conditions

• Polycystic Ovarian Syndrome (PCOS)

Interventions

Type	Name	Description
DEVICE	Stelo glucose biosensor by Dexcom	Unblinded continuous glucose monitoring (CGM) system

Timeline

• Start date: 2025-12-24
• Primary completion: 2026-12-31
• Completion: 2027-08-15
• First posted: 2026-02-06
• Last updated: 2026-02-06

Locations

1 site across 1 country: United States